Aprea Therapeutics, Inc.
ロング

APRE

240
Aprea Therapeutics Inc (NASDAQ:APRE) The last few days the stock has seen increased volume and price. From a technical standpoint, the stock looks to have bottomed. It broke the falling wedge pattern and could eventually rally up to test its 100-day EMA in the coming days. In addition, MACD, RSI and ADX also indicate positive momentum. To think APRE was trading at $8.4 not long ago. This is worth watching and possibly stepping in for a trade.

免責事項

これらの情報および投稿は、TradingViewが提供または承認する金融、投資、取引、またはその他の種類の助言もしくは推奨であることを意図したものではなく、またこれらに該当するものでもありません。詳細は利用規約をご覧ください。